Review
Oct 2026
Phase 3 Antifibrotic-Directed Therapy Outcomes in Idiopathic Pulmonary Fibrosis: Beyond FVC Decline
Fumihiro Kashizaki, Shohei Watanabe, Ryusuke Orii et al.
· Lung · 0 citations